Intraday data delayed at least 15 minutes or per exchange requirements. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.

NightHawk Biosciences’ stock is owned by many different retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%). Insiders that own company stock include Edward B Smith III and John K A Prendergast. Sign-up to receive the latest news and ratings for NightHawk Biosciences and its competitors with MarketBeat’s FREE daily newsletter. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index quotes are real-time.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.

A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade. NEW YORK — Visicu Inc. vaulted as much as 62% in its stock market debut Wednesday as investors bid up shares of the company whose technology helps hospitals monitor intensive-care patients. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed.

• The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• It’s calculated by multiplying the current market price by the total number of shares outstanding.
• We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
• Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.

If you aren’t doing this a couple times a week, you need to start. Grab your salt and pour some directly down your drain at night. Bloomberg Businessweek Highlights from a week-long virtual event bringing Bloomberg Businessweek magazine to life.

The company has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is headquartered in Morrisville, North Carolina. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. NEW YORK — Exco Resources Inc. on Thursday traded at a slight premium after pricing its initial public offering atop the planned range. A roundup of the latest corporate earnings reports and what companies are saying about future quarters. The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023. Join thousands of traders who make more informed decisions with our premium features.

We also https://1investing.in/ both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM , a monoclonal antibody antitoxin for the treatment of inhalational anthrax. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends.

Stocks That Hit 52-Week Lows On Tuesday

Morningstar Quantitative ratings for equities are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.

Sell every Stock except ONE Markets are down…But Jeff Clark couldn’t care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month… Maintaining independence and editorial freedom is essential to our mission of empowering investor success.

The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. Represents the company’s profit divided by the outstanding shares of its common stock.

It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. NEW YORK — Chipotle Mexican Grill Inc., American Railcar Industries and NightHawk Radiology Services turned in the best year-to-date gains among the 32 initial public offerings so far as the first two months… NEW YORK — NightHawk Radiology CEO Dr. Paul Berger got a good clue of the coming success of his company’s initial public offering when he met with investors on his IPO road show.

Media Services

These are established companies that reliably pay dividends. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades.

Carol Massar and Tim Stenovec host a look back at the best interviews, discussions and more. Upgrade to MarketBeat All Access to add more stocks to your watchlist. NightHawk Biosciences trades on the New York Stock Exchange under the ticker symbol “NHWK.”

NightHawk Biosciences (NHWK) Stock Forecast, Price & News

In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. 1 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for NightHawk Biosciences in the last twelve months.

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. Provide specific products and services to you, such as portfolio management or data aggregation. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

Real-time quotes, advanced visualizations, backtesting, and much more. Verify your identity, personalize the content you receive, or create and administer your account. We’d like to share more about how we work and what drives our day-to-day business. CompareNHWK’s historical performanceagainst its industry peers and the overall market. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity.

Stock Money Flow

The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. NightHawk Biosciences, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient’s T-cell mediated immune system against cancer. Its TCAP product candidates from the company’s ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

• Data may be intentionally delayed pursuant to supplier requirements.
• Sign Up NowGet this delivered to your inbox, and more info about our products and services.
• ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
• Top institutional investors include Simplex Trading LLC (0.00%).
• The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

spillover Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price. NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company’s therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors.

Industry Products

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research. Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s.

To see all exchange delays and terms of use please see Barchart’s disclaimer. Real-time analyst ratings, insider transactions, earnings data, and more. The Company specializes in the end-to-end development, manufacturing, and commercialization of medical countermeasures that combat unmet and emerging biothreats. It provides process development and biomanufacturing services to support its biotherapeutics and discovery pipeline. The Company’s monoclonal antibody ANTHIM is a monoclonal antibody that binds the protective antigen component of… NightHawk Biosciences shares reverse split before market open on Friday, December 11th 2020.

STOCKS EXTEND GAINS AMID TECH EARNINGS, BANKING DRAMA

It can also be calculated by dividing the company’s Market Cap by the Net Profit. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.

The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. Sign Up NowGet this delivered to your inbox, and more info about our products and services. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. NightHawk Biosciences Inc 52 week low is $0.66 as of April 28, 2023.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.